ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognosis prediction and risk stratification of transarterial chemoembolization or intraarterial chemotherapy for unresectable hepatocellular carcinoma based on machine learning

Liu, Wendao; Wei, Ran; Chen, Junwei; Li, Yangyang; Pang, Huajin; Zhang, Wentao; An, Chao*; Li, Chengzhi*广东省人民医院; 南昌大学; 南方医科大学; 中山大学; 1
European Radiology2024-1-30DOI: 10.1007/s00330-024-10581-2
3阅读
引用收藏
分享

摘要

Objective To develop and validate a risk scoring scale model (RSSM) for stratifying prognostic risk after intra-arterial therapies (IATs) for hepatocellular carcinoma (HCC). Methods Between February 2014 and October 2022, 2338 patients with HCC who underwent initial IATs were consecutively enrolled. These patients were divided into training datasets (TD, n = 1700), internal validation datasets (ITD, n = 428), and external validation datasets (ETD, n = 200). Five-years death was used to predict outcome. Thirty-four clinical information were input and five supervised machine learning (ML) algorithms, including eXtreme Gradient Boosting (XGBoost), Categorical Gradient Boosting (CatBoost), Gradient Boosting Decision Tree (GBDT), Light Gradient Boosting Machine (LGBT), and Random Forest (RF), were compared using the areas under the receiver operating characteristic (AUC) with DeLong test. The variables with top important ML scores were used to build the RSSM by stepwise Cox regression. Results The CatBoost model achieved the best discrimination when 12 top variables were input, with the AUC of 0.851 (95% confidence intervals (CI), 0.833-0.868) for TD, 0.817 (95%CI, 0.759-0.857) for ITD, and 0.791 (95%CI, 0.748-0.834) for ETD. The RSSM was developed based on the immune checkpoint inhibitors (ICI) (hazard ratios (HR), 0.678; 95%CI 0.549, 0.837), tyrosine kinase inhibitors (TKI) (HR, 0.702; 95%CI 0.605, 0.814), local therapy (HR, 0.104; 95%CI 0.014, 0.747), response to the first IAT (HR, 4.221; 95%CI 2.229, 7.994), tumor size (HR, 1.054; 95%CI 1.038, 1.070), and BCLC grade (HR, 2.375; 95%CI 1.950, 2.894). Kaplan-Meier analysis confirmed the role of RSSM in risk stratification (p < 0.001). Conclusions The RSSM can stratify accurately prognostic risk for HCC patients received IAT. On the basis, an online calculator permits easy implementation of this model.

学科与关键词

关键词
Intra-arterial therapiesHepatocellular carcinomaRisk scoring scale modelMachine learningRisk stratification
相关
加载中…
  • The prognostic role of an optimal machine learning model based on clinical available indicators in HCC patients
    Lou, Xiaoying; Ma, Shaohui; Ma, Mingyuan; Wu, Yue; Xuan, Chengmei; Sun, Yan; Liang, Yue; Wang, Zongdan; Gao, Hongjun*Frontiers in Medicine, 2024, 11: 1431578.被引 1
  • Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma
    Alaimo, Laura; Lima, Henrique A.; Moazzam, Zorays; Endo, Yutaka; Yang, Jason; Ruzzenente, Andrea; Guglielmi, Alfredo; Aldrighetti, Luca; Weiss, Matthew; Bauer, Todd W. W.; Alexandrescu, Sorin; Poultsides, George A. A.; Maithel, Shishir K. K.; Marques, Hugo P. P.; Martel, Guillaume; Pulitano, Carlo; Shen, Feng; Cauchy, Francois; Koerkamp, Bas Groot; Endo, Itaru; Kitago, Minoru; Pawlik, Timothy M. M.*Annals of Surgical Oncology, 2023, 30(9): 5406-5415.被引 14
  • An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma
    Zhang, Lu; Jin, Zhe; Li, Chen; He, Zicong; Zhang, Bin; Chen, Qiuying; You, Jingjing; Ma, Xiao; Shen, Hui; Wang, Fei; Wu, Lingeng*; Ma, Cunwen*; Zhang, Shuixing*Radiologia Medica, 2024.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Radiology
发表日期
2024-01-30
DOI
10.1007/s00330-024-10581-2
语言
ENGLISH
成果收录
SCIE
资助标注
Medical Scientific Research Foundation of Guangdong Province, China [202242915212755]

作者

  • L

    Liu, Wendao (第一作者)

    guangdong prov hosp · guangdong prov acad chinese med sci

  • W

    Wei, Ran

    1 · sun yat sen univ

查看全部 8 位作者收起作者
  • C

    Chen, Junwei

    sun yat sen univ

  • L

    Li, Yangyang

    1

  • P

    Pang, Huajin

    southern med univ

  • Z

    Zhang, Wentao

    1 · nanchang univ

  • A

    An, Chao (通讯)

    sun yat sen univ

  • L

    Li, Chengzhi (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417